{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:13:11Z","timestamp":1792793591601,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prophylactic radioprotectors for pre-exposure administration are notably absent, creating a critical gap in radiation emergency preparedness and ARS management. BIO 300, a wet-nanomilled formulation of synthetic genistein, is in advanced development as a prophylactic radioprotector with demonstrated survival benefits in murine and nonhuman primate (NHP) models when administered prior to lethal radiation exposure. Longitudinal transcriptomic analysis enables characterization of the molecular mechanisms underlying radioprotective drug action and supports development of potential blood-based monitoring tools for clinical translation. We performed longitudinal blood transcriptome profiling in NHPs receiving 5.8\u2009Gy total-body irradiation to characterize BIO 300\u2018s radioprotective mechanisms and identify candidate transcriptional biomarkers of drug activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BIO 300 demonstrated multiphasic changes in the transcriptome spanning acute cellular preservation (Days 7\u201310), immune reconstitution (Day 21), and sustained recovery (Day 60), with peak protection spanning 745\u2013865 genes at Days 7\u201310 and sustained late-phase protection of 558 genes at Day 60. Differential expression analysis revealed four distinct drug-related molecular mechanisms: direct cellular protection, active damage reversal, drug-specific therapeutic responses, and stress attenuation. A core set of 39 genes showing sustained or consistent differential expression was identified, of which 20 carry conventional gene symbols and are functionally interpretable; LOC-designated genes are excluded from functional annotation. Notable annotated genes include SOX2, AKAP11, TIMD4, BTNL10, VNN2, and CLEC1A, representing candidate exploratory transcriptional markers consistent with hematopoietic recovery and immune surveillance. Temporally orchestrated pathway signatures include neuroimmune modulation (Day 7), hemostatic recovery (Day 14), and immunometabolic reconstitution (Day 21).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results show that BIO 300 provides multiphasic radioprotection across acute, immune reconstitution, and sustained recovery phases through four distinct mechanisms. Longitudinal transcriptomic signatures identified in this study represent potential blood-based monitoring tools for therapeutic efficacy assessment toward the continued development of BIO 300.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08485-4","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:25:13Z","timestamp":1782811513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiphasic blood transcriptomic signatures of radioprotection by BIO 300, a synthetic genistein nanosuspension, in a nonhuman primate model of acute radiation syndrome"],"prefix":"10.1186","volume":"24","author":[{"given":"Neetha","family":"Nanoth Vellichirammal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-7455","authenticated-orcid":false,"given":"Stephen Y.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-2497","authenticated-orcid":false,"given":"Oluseyi O.","family":"Fatanmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1729-5139","authenticated-orcid":false,"given":"Rachel C.","family":"Mingus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana D.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2645-7570","authenticated-orcid":false,"given":"Sarah A.","family":"Petrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-6259","authenticated-orcid":false,"given":"Michael D.","family":"Kaytor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-3849","authenticated-orcid":false,"given":"Vijay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"6","key":"8485_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/MOH.0000000000000380","volume":"24","author":"RP Gale","year":"2017","unstructured":"Gale RP. Medical and policy considerations for nuclear and radiation accidents, incidents and terrorism. Curr Opin Hematol. 2017;24(6):496\u2013501. https:\/\/doi.org\/10.1097\/MOH.0000000000000380.","journal-title":"Curr Opin Hematol"},{"issue":"13","key":"8485_CR2","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1056\/NEJMsr1714289","volume":"378","author":"RP Gale","year":"2018","unstructured":"Gale RP, Armitage JO. Are we prepared for nuclear terrorism? N Engl J Med. 2018;378(13):1246\u201354. https:\/\/doi.org\/10.1056\/NEJMsr1714289.","journal-title":"N Engl J Med"},{"key":"8485_CR3","volume-title":"Radiobiology for the Radiobiologist","author":"EJ Hall","year":"2012","unstructured":"Hall EJ, Giaccia AJ. Radiobiology for the Radiobiologist. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2012.","edition":"7"},{"issue":"4","key":"8485_CR4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.rpor.2011.05.001","volume":"16","author":"M Lopez","year":"2011","unstructured":"Lopez M, Martin M. Medical management of the acute radiation syndrome. Rep Pract Oncol Radiother. 2011;16(4):138\u201346. https:\/\/doi.org\/10.1016\/j.rpor.2011.05.001.","journal-title":"Rep Pract Oncol Radiother"},{"key":"8485_CR5","unstructured":"U.S. Food and Drug Administration. Radiological and nuclear emergency preparedness information from FDA. Available at: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/radiological-and-nuclear-emergency-preparedness-information-fda"},{"issue":"9","key":"8485_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1358\/dot.2015.51.9.2386730","volume":"51","author":"AM Farese","year":"2015","unstructured":"Farese AM, MacVittie TJ. Filgrastim for the treatment of hematopoietic acute radiation syndrome. Drugs Today. 2015;51(9):537\u201348. https:\/\/doi.org\/10.1358\/dot.2015.51.9.2386730.","journal-title":"Drugs Today"},{"issue":"6","key":"8485_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1667\/RR13940.1","volume":"183","author":"KG Hankey","year":"2015","unstructured":"Hankey KG, Farese AM, Blaauw EC, Gibbs AM, Smith CP, Katz BP, et al. Pegfilgrastim improves survival of lethally irradiated nonhuman primates. Radiat Res. 2015;183(6):643\u201355. https:\/\/doi.org\/10.1667\/RR13940.1.","journal-title":"Radiat Res"},{"issue":"11","key":"8485_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1358\/dot.2018.54.11.2899370","volume":"54","author":"VK Singh","year":"2018","unstructured":"Singh VK, Seed TM. An update on sargramostim for treatment of acute radiation syndrome. Drugs Today. 2018;54(11):679\u201393. https:\/\/doi.org\/10.1358\/dot.2018.54.11.2899370.","journal-title":"Drugs Today"},{"key":"8485_CR9","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1080\/09553002.2019.1673499","volume":"97","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Pouliot M, Downey AM, Mockbee C, Roychowdhury D, Wierzbicki W, et al. Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model. Int J Radiat Biol. 2021;97:S100\u201316. https:\/\/doi.org\/10.1080\/09553002.2019.1673499.","journal-title":"Int J Radiat Biol"},{"key":"8485_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1667\/RADE-20-00131.1","volume":"195","author":"NP Clayton","year":"2021","unstructured":"Clayton NP, Khan-Malek RC, Dangler CA, Zhang D, Ascah A, Gains M, et al. Sargramostim (rhu GM-CSF) improves survival of non-human primates with severe bone marrow suppression after acute, high-dose, whole-body irradiation. Radiat Res. 2021;195:191\u201399. https:\/\/doi.org\/10.1667\/RADE-20-00131.1.","journal-title":"Radiat Res"},{"key":"8485_CR11","unstructured":"U.S. Food and Drug Administration. Animal Rule approvals. Available at: https:\/\/www.fda.gov\/drugs\/nda-and-bla-approvals\/animal-rule-approvals"},{"issue":"1","key":"8485_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/09553002.2019.1625488","volume":"96","author":"K Wong","year":"2020","unstructured":"Wong K, Chang PY, Fielden M, Downey AM, Bunin D, Bakke J, et al. Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. Int J Radiat Biol. 2020;96(1):155\u201366. https:\/\/doi.org\/10.1080\/09553002.2019.1625488.","journal-title":"Int J Radiat Biol"},{"key":"8485_CR13","doi-asserted-by":"publisher","first-page":"100690","DOI":"10.1016\/j.blre.2020.100690","volume":"45","author":"RP Gale","year":"2020","unstructured":"Gale RP, Armitage JO. Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations. Blood Rev. 2020;45:100690. https:\/\/doi.org\/10.1016\/j.blre.2020.100690.","journal-title":"Blood Rev"},{"issue":"1","key":"8485_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1667\/RR3049.1","volume":"179","author":"AM Farese","year":"2013","unstructured":"Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, et al. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 2013;179(1):89\u2013100. https:\/\/doi.org\/10.1667\/RR3049.1.","journal-title":"Radiat Res"},{"issue":"11","key":"8485_CR15","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1080\/09553002.2021.1969054","volume":"97","author":"VK Singh","year":"2021","unstructured":"Singh VK, Seed TM. Radiation countermeasures for hematopoietic acute radiation syndrome: growth factors, cytokines and beyond. Int J Radiat Biol. 2021;97(11):1526\u201347. https:\/\/doi.org\/10.1080\/09553002.2021.1969054.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"8485_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/09553002.2019.1605465","volume":"96","author":"DI Bunin","year":"2020","unstructured":"Bunin DI, Bakke J, Green CE, Javitz HS, Fielden M, Chang PY. Romiplostim (Nplate) as an effective radiation countermeasure to improve survival and platelet recovery in mice. Int J Radiat Biol. 2020;96(1):145\u201354. https:\/\/doi.org\/10.1080\/09553002.2019.1605465.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"8485_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.ijrobp.2023.05.008","volume":"17","author":"DI Bunin","year":"2023","unstructured":"Bunin DI, Javitz HS, Gahagen J, Bakke J, Lane JH, Andrews DA, et al. Survival and hematologic benefits of romiplostim after acute radiation exposure supported FDA approval under the animal rule. Int J Radiat Oncol Biol Phys. 2023;17(1):705\u201317. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.008.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8485_CR18","unstructured":"U.S. Food and Drug Administration. Guidance document: Product development under the Animal Rule. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm399217.pdf"},{"key":"8485_CR19","unstructured":"U.S. Food and Drug Administration. Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/acute-radiation-syndrome-developing-drugs-prevention-and-treatment"},{"issue":"5","key":"8485_CR20","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1667\/RADE-23-00144.1","volume":"201","author":"DR Cassatt","year":"2024","unstructured":"Cassatt DR, DiCarlo AL, Molinar-Inglis O. Product Development within the National Institutes of Health Radiation and Nuclear Countermeasures Program. Radiat Res. 2024;201(5):471\u201378. https:\/\/doi.org\/10.1667\/RADE-23-00144.1.","journal-title":"Radiat Res"},{"issue":"4","key":"8485_CR21","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.ijrobp.2008.03.043","volume":"71","author":"S Paul","year":"2008","unstructured":"Paul S, Amundson SA. Development of gene expression signatures for practical radiation biodosimetry. Int J Radiat Oncol Biol Phys. 2008;71(4):1236\u201344. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.03.043.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"8485_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/09553002.2017.1332438","volume":"93","author":"VK Singh","year":"2017","unstructured":"Singh VK, Seed TM. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. Int J Radiat Biol. 2017;93(9):851\u201369. https:\/\/doi.org\/10.1080\/09553002.2017.1332438.","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"8485_CR23","doi-asserted-by":"publisher","first-page":"e1912","DOI":"10.1371\/journal.pone.0001912","volume":"3","author":"SK Meadows","year":"2008","unstructured":"Meadows SK, Dressman HK, Muramoto GG, Himburg H, Salter A, Wei Z, et al. Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS ONE. 2008;3(4):e1912. https:\/\/doi.org\/10.1371\/journal.pone.0001912.","journal-title":"PLoS ONE"},{"issue":"5","key":"8485_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1080\/13543784.2020.1757648","volume":"29","author":"VK Singh","year":"2020","unstructured":"Singh VK, Seed TM. BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure. Expert Opin Investig Drugs. 2020;29(5):429\u201341. https:\/\/doi.org\/10.1080\/13543784.2020.1757648.","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"8485_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1667\/RADE-22-00142.1","volume":"199","author":"VK Singh","year":"2023","unstructured":"Singh VK, Serebrenik AA, Fatanmi OO, Wise SY, Carpenter AD, Janocha BL, et al. The radioprotectant, BIO 300, protects the lungs from total-body irradiation injury in C57L\/J mice. Radiat Res. 2023;199(3):294\u2013300. https:\/\/doi.org\/10.1667\/RADE-22-00142.1.","journal-title":"Radiat Res"},{"issue":"Supplement3","key":"8485_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/milmed\/usae156","volume":"189","author":"VK Singh","year":"2024","unstructured":"Singh VK, Serebrenik AA, Wise SY, Petrus SA, Fatanmi OO, Kaytor MD. BIO 300: A prophylactic radiation countermeasure for acute radiation syndrome. Mil Med. 2024;189(Supplement3):390\u201398. https:\/\/doi.org\/10.1093\/milmed\/usae156.","journal-title":"Mil Med"},{"issue":"2","key":"8485_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/cpdd.1188","volume":"12","author":"AA Serebrenik","year":"2023","unstructured":"Serebrenik AA, Verduyn CW, Kaytor MD. Safety, pharmacokinetics, and biomarkers of an amorphous Solid dispersion of genistein, a radioprotectant, in healthy volunteers. Clin Pharmacol Drug Dev. 2023;12(2):190\u2013201. https:\/\/doi.org\/10.1002\/cpdd.1188.","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"3","key":"8485_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/jrr\/rrz014","volume":"60","author":"MR Landauer","year":"2019","unstructured":"Landauer MR, Harvey AJ, Kaytor MD, Day RM. Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome. J Radiat Res. 2019;60(3):308\u201317. https:\/\/doi.org\/10.1093\/jrr\/rrz014.","journal-title":"J Radiat Res"},{"issue":"Supplement2","key":"8485_CR29","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/milmed\/usaf325","volume":"190","author":"OO Fatanmi","year":"2025","unstructured":"Fatanmi OO, Wise SY, Petrus SA, Melendez-Miranda I, Carpenter AD, Olson HM, et al. Prophylactic Administration of BIO 300, A Radiation Medical Countermeasure, Improves Erythrocyte-Associated Parameters in the Rhesus Macaque Model. Mil Med. 2025;190(Supplement2):746\u201354. https:\/\/doi.org\/10.1093\/milmed\/usaf325.","journal-title":"Mil Med"},{"issue":"1","key":"8485_CR30","doi-asserted-by":"publisher","first-page":"13475","DOI":"10.1038\/s41598-022-17807-7","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Girgis M, Jayatilake M, Serebrenik AA, Cheema AK, Kaytor MD, et al. Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates. Sci Rep. 2022;12(1):13475. https:\/\/doi.org\/10.1038\/s41598-022-17807-7.","journal-title":"Sci Rep"},{"issue":"5","key":"8485_CR31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/ijms20051231","volume":"20","author":"AK Cheema","year":"2019","unstructured":"Cheema AK, Mehta KY, Santiago PT, Fatanmi OO, Kaytor MD, Singh VK. Pharmacokinetic and metabolomic studies with BIO 300, a nanosuspension of genistein, in a nonhuman primate model. Int J Mol Sci. 2019;20(5):1231. https:\/\/doi.org\/10.3390\/ijms20051231.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"8485_CR32","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s11095-017-2200-9","volume":"34","author":"JW Jones","year":"2017","unstructured":"Jones JW, Jackson IL, Vujaskovic Z, Kaytor MD, Kane MA. Targeted metabolomics identifies pharmacodynamic biomarkers for BIO 300 mitigation of radiation-induced lung injury. Pharm Res. 2017;34(12):2698\u2013709. https:\/\/doi.org\/10.1007\/s11095-017-2200-9.","journal-title":"Pharm Res"},{"key":"8485_CR33","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals. 8 ed. National Academies; 2011."},{"key":"8485_CR34","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1080\/09553002.2021.1981556","volume":"98","author":"VK Singh","year":"2022","unstructured":"Singh VK, Fatanmi OO, Wise SY, Carpenter A, Nakamura-Peek S, Serebrenik AA, et al. A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice. Int J Radiat Biol. 2022;98:958\u201367. https:\/\/doi.org\/10.1080\/09553002.2021.1981556.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"8485_CR35","doi-asserted-by":"publisher","first-page":"11449","DOI":"10.1038\/s41598-021-91067-9","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Girgis M, Wise SY, Fatanmi OO, Seed TM, Maniar M, et al. Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure. Sci Rep. 2021;11(1):11449. https:\/\/doi.org\/10.1038\/s41598-021-91067-9.","journal-title":"Sci Rep"},{"issue":"5","key":"8485_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1667\/RADE-24-00223.1","volume":"203","author":"I Melendez-Miranda","year":"2025","unstructured":"Melendez-Miranda I, Fatanmi OO, Wise SY, Petrus SA, Carpenter AD, Olsen C, et al. Lethality assessments for acutely irradiated cynomolgus macaques under subject-based care. Radiat Res. 2025;203(5):304\u201320. https:\/\/doi.org\/10.1667\/RADE-24-00223.1.","journal-title":"Radiat Res"},{"issue":"1","key":"8485_CR37","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1038\/s41598-021-85669-6","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Singh J, Varghese R, Zhang Y, Fatanmi OO, Cheema AK, et al. Transcriptome of rhesus macaque (Macaca mulatta) exposed to total-body irradiation. Sci Rep. 2021;11(1):6295. https:\/\/doi.org\/10.1038\/s41598-021-85669-6.","journal-title":"Sci Rep"},{"key":"8485_CR38","doi-asserted-by":"publisher","unstructured":"Farese AM, Cohen MV, Katz BP, Smith CP, Jackson W 3rd, Cohen DM, et al. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 2012;103(4):367\u201382. https:\/\/doi.org\/10.1097\/HP.0b013e31825f75a7.","DOI":"10.1097\/HP.0b013e31825f75a7"},{"issue":"6","key":"8485_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1667\/RADE-22-00101.1","volume":"198","author":"VK Singh","year":"2022","unstructured":"Singh VK, Fatanmi OO, Wise SY, Carpenter AD, Olsen CH. Determination of lethality curve for cobalt-60 gamma-radiation source in rhesus macaques using subject-based supportive care. Radiat Res. 2022;198(6):599\u2013614. https:\/\/doi.org\/10.1667\/RADE-22-00101.1.","journal-title":"Radiat Res"},{"key":"8485_CR40","unstructured":"Leary S, Underwood W, Anthony R, Cartner S, Grandin T, Greenacre CB et al. AVMA Guidelines for Euthanasia of Animals, vol. 2020.0.1: American Veterinary Medical Association; 2020."},{"key":"8485_CR41","unstructured":"Andrews S. FASTQC. A quality control tool for high throughput sequence data. Available at: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"issue":"12","key":"8485_CR42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"1","key":"8485_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/jrr\/rrab091","volume":"63","author":"F Fang","year":"2022","unstructured":"Fang F, Yu X, Wang X, Zhu X, Liu L, Rong L, et al. Transcriptomic profiling reveals gene expression in human peripheral blood after exposure to low-dose ionizing radiation. J Radiat Res. 2022;63(1):8\u201318. https:\/\/doi.org\/10.1093\/jrr\/rrab091.","journal-title":"J Radiat Res"},{"issue":"2","key":"8485_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1667\/RR15476.1","volume":"193","author":"L Cruz-Garcia","year":"2020","unstructured":"Cruz-Garcia L, O\u2019Brien G, Sipos B, Mayes S, Love MI, Turner DJ, et al. Generation of a Transcriptional Radiation Exposure Signature in Human Blood Using Long-Read Nanopore Sequencing. Radiat Res. 2020;193(2):143\u201354. https:\/\/doi.org\/10.1667\/RR15476.1.","journal-title":"Radiat Res"},{"issue":"1","key":"8485_CR45","doi-asserted-by":"publisher","first-page":"19840","DOI":"10.1038\/s41598-025-04898-1","volume":"15","author":"A Salah","year":"2025","unstructured":"Salah A, Wollschlager D, Callari M, Schmidberger H, Marini F, Zahnreich S. Genome-wide transcriptomic response of whole blood to radiation. Sci Rep. 2025;15(1):19840. https:\/\/doi.org\/10.1038\/s41598-025-04898-1.","journal-title":"Sci Rep"},{"issue":"5","key":"8485_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1667\/RADE-21-00114.1","volume":"197","author":"AM Salem","year":"2022","unstructured":"Salem AM, Jackson IL, Gibbs A, Poirier Y, Newman D, Zodda A, et al. Interspecies Comparison and Radiation Effect on Pharmacokinetics of BIO 300, a Nanosuspension of Genistein, after Different Routes of Administration in Mice and Non-Human Primates. Radiat Res. 2022;197(5):447\u201358. https:\/\/doi.org\/10.1667\/RADE-21-00114.1.","journal-title":"Radiat Res"},{"key":"8485_CR47","doi-asserted-by":"publisher","unstructured":"Carpenter AD, Li Y, Packer BE, Fatanmi OO, Wise SY, Petrus SA, et al. Serum Metabolomic Signatures in Nonhuman Primates Treated with a Countermeasure and Exposed to Partial- or Total-Body Radiation. Metabolites. 2025;15(8). https:\/\/doi.org\/10.3390\/metabo15080546.","DOI":"10.3390\/metabo15080546"},{"issue":"9","key":"8485_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/09553000802317778","volume":"84","author":"TA Davis","year":"2008","unstructured":"Davis TA, Mungunsukh O, Zins S, Day RM, Landauer MR. Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol. 2008;84(9):713\u201326. https:\/\/doi.org\/10.1080\/09553000802317778.","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"8485_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/HP.0b013e318266eb4c","volume":"103","author":"TJ MacVittie","year":"2012","unstructured":"MacVittie TJ, Bennett A, Booth C, Garofalo M, Tudor G, Ward A, et al. The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation. Health Phys. 2012;103(4):427\u201353. https:\/\/doi.org\/10.1097\/HP.0b013e318266eb4c.","journal-title":"Health Phys"},{"issue":"1","key":"8485_CR50","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41467-025-67214-5","volume":"17","author":"W Yu","year":"2025","unstructured":"Yu W, Jiao K, Wang K, Li X, Wan Q, Qin W, et al. Metabolic support protects mucosa from ferroptosis in radiation-induced mucositis. Nat Commun. 2025;17(1):520. https:\/\/doi.org\/10.1038\/s41467-025-67214-5.","journal-title":"Nat Commun"},{"key":"8485_CR51","doi-asserted-by":"publisher","unstructured":"Li XWK-Y, Qin W, Wei-Wei Y, Xin-Yi H. Zinc-releasing adhesive oral patch for prevention of radiation-induced oral ulcerative mucositis. Chem Eng J. 2025;517. https:\/\/doi.org\/10.1016\/j.cej.2025.164307.","DOI":"10.1016\/j.cej.2025.164307"},{"issue":"7","key":"8485_CR52","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1080\/09553002.2023.2187479","volume":"99","author":"T Wu","year":"2023","unstructured":"Wu T, Orschell CM. The delayed effects of acute radiation exposure (DEARE): characteristics, mechanisms, animal models, and promising medical countermeasures. Int J Radiat Biol. 2023;99(7):1066\u201379. https:\/\/doi.org\/10.1080\/09553002.2023.2187479.","journal-title":"Int J Radiat Biol"},{"issue":"26","key":"8485_CR53","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1073\/pnas.96.26.14973","volume":"96","author":"R Khosravi","year":"1999","unstructured":"Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A. 1999;96(26):14973\u20137. https:\/\/doi.org\/10.1073\/pnas.96.26.14973.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8485_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12032-024-02586-0","volume":"42","author":"M Lin","year":"2025","unstructured":"Lin M, Mo Y, Li CM, Liu YZ, Feng XP. GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells. Med Oncol. 2025;42(2):49. https:\/\/doi.org\/10.1007\/s12032-024-02586-0.","journal-title":"Med Oncol"},{"issue":"11","key":"8485_CR55","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock KL, Reits E, Neefjes J. Present Yourself! By MHC Class I and MHC Class II Molecules. Trends Immunol. 2016;37(11):724\u201337. https:\/\/doi.org\/10.1016\/j.it.2016.08.010.","journal-title":"Trends Immunol"},{"issue":"9","key":"8485_CR56","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","volume":"12","author":"D Schaue","year":"2015","unstructured":"Schaue D, McBride WH. Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015;12(9):527\u201340. https:\/\/doi.org\/10.1038\/nrclinonc.2015.120.","journal-title":"Nat Rev Clin Oncol"},{"key":"8485_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2018.07.003","volume":"133","author":"T Ganz","year":"2019","unstructured":"Ganz T. Erythropoietic regulators of iron metabolism. Free Radic Biol Med. 2019;133:69\u201374. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.07.003.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"8485_CR58","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/17460441.2017.1323863","volume":"12","author":"VK Singh","year":"2017","unstructured":"Singh VK, Olabisi AO. Nonhuman primates as models for the discovery and development of radiation countermeasures. Expert Opin Drug Discov. 2017;12(7):695\u2013709. https:\/\/doi.org\/10.1080\/17460441.2017.1323863.","journal-title":"Expert Opin Drug Discov"},{"key":"8485_CR59","doi-asserted-by":"publisher","first-page":"592980","DOI":"10.4061\/2010\/592980","volume":"2010","author":"RP Rastogi","year":"2010","unstructured":"Rastogi RP, Richa, Kumar A, Tyagi MB, Sinha RP. Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids. 2010;2010:592980. https:\/\/doi.org\/10.4061\/2010\/592980.","journal-title":"J Nucleic Acids"},{"issue":"6","key":"8485_CR60","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1634\/theoncologist.12-6-738","volume":"12","author":"JR Kouvaris","year":"2007","unstructured":"Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist. 2007;12(6):738\u201347. https:\/\/doi.org\/10.1634\/theoncologist.12-6-738.","journal-title":"Oncologist"},{"issue":"6","key":"8485_CR61","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","volume":"27","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927\u201340. https:\/\/doi.org\/10.1016\/j.immuni.2007.11.011.","journal-title":"Immunity"},{"issue":"8","key":"8485_CR62","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri3715","volume":"14","author":"HA Arnett","year":"2014","unstructured":"Arnett HA, Viney JL. Immune modulation by butyrophilins. Nat Rev Immunol. 2014;14(8):559\u201369. https:\/\/doi.org\/10.1038\/nri3715.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8485_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1254\/jphs.13r01cp","volume":"123","author":"T Nitto","year":"2013","unstructured":"Nitto T, Onodera K. Linkage between coenzyme a metabolism and inflammation: roles of pantetheinase. J Pharmacol Sci. 2013;123(1):1\u20138. https:\/\/doi.org\/10.1254\/jphs.13r01cp.","journal-title":"J Pharmacol Sci"},{"issue":"7","key":"8485_CR64","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.4049\/jimmunol.162.7.4277","volume":"162","author":"K Suzuki","year":"1999","unstructured":"Suzuki K, Watanabe T, Sakurai S, Ohtake K, Kinoshita T, Araki A, et al. A novel glycosylphosphatidyl inositol-anchored protein on human leukocytes: a possible role for regulation of neutrophil adherence and migration. J Immunol. 1999;162(7):4277\u201384.","journal-title":"J Immunol"},{"issue":"46","key":"8485_CR65","doi-asserted-by":"publisher","first-page":"eabo7621","DOI":"10.1126\/sciadv.abo7621","volume":"8","author":"M Drouin","year":"2022","unstructured":"Drouin M, Saenz J, Gauttier V, Evrard B, Teppaz G, Pengam S, et al. CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy. Sci Adv. 2022;8(46):eabo7621. https:\/\/doi.org\/10.1126\/sciadv.abo7621.","journal-title":"Sci Adv"},{"issue":"4","key":"8485_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.stem.2011.09.001","volume":"9","author":"K Arnold","year":"2011","unstructured":"Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, et al. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell. 2011;9(4):317\u201329. https:\/\/doi.org\/10.1016\/j.stem.2011.09.001.","journal-title":"Cell Stem Cell"},{"key":"8485_CR67","doi-asserted-by":"publisher","unstructured":"Deng Z, Li X, Blanca Ramirez M, Purtell K, Choi I, Lu JH, et al. Selective autophagy of AKAP11 activates cAMP\/PKA to fuel mitochondrial metabolism and tumor cell growth. Proc Natl Acad Sci U S A. 2021;118(14). https:\/\/doi.org\/10.1073\/pnas.2020215118.","DOI":"10.1073\/pnas.2020215118"},{"issue":"9","key":"8485_CR68","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1089\/ars.2013.5635","volume":"20","author":"L Shao","year":"2014","unstructured":"Shao L, Luo Y, Zhou D. Hematopoietic stem cell injury induced by ionizing radiation. Antioxid Redox Signal. 2014;20(9):1447\u201362. https:\/\/doi.org\/10.1089\/ars.2013.5635.","journal-title":"Antioxid Redox Signal"},{"issue":"Supplement 1","key":"8485_CR69","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1182\/blood-2024-208493","volume":"144","author":"Y Zou","year":"2024","unstructured":"Zou Y, Bardahl J, Jiao Y, Yang J, Dai D, Wolfarth A, et al. NT-I7, a Long-Acting Interleukin-7 Molecule, Promotes T Cell Reconstitution Following Radiation Injury through Thymic-Dependent and Independent Pathways. Blood. 2024;144(Supplement 1):320\u201335. https:\/\/doi.org\/10.1182\/blood-2024-208493.","journal-title":"Blood"},{"issue":"5","key":"8485_CR70","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ijrobp.2011.03.039","volume":"80","author":"MP Lambert","year":"2011","unstructured":"Lambert MP, Xiao L, Nguyen Y, Kowalska MA, Poncz M. The role of platelet factor 4 in radiation-induced thrombocytopenia. Int J Radiat Oncol Biol Phys. 2011;80(5):1533\u201340. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.03.039.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"8485_CR71","doi-asserted-by":"publisher","first-page":"e0001","DOI":"10.1667\/rrol01.1","volume":"176","author":"AL DiCarlo","year":"2011","unstructured":"DiCarlo AL, Poncz M, Cassatt DR, Shah JR, Czarniecki CW, Maidment BW. Medical countermeasures for platelet regeneration after radiation exposure. Report of a workshop and guided discussion sponsored by the National Institute of Allergy and Infectious Diseases, Bethesda, MD, March 22-23, 2010. Radiat Res. 2011;176(1):e0001\u201315. https:\/\/doi.org\/10.1667\/rrol01.1.","journal-title":"Radiat Res"},{"issue":"4","key":"8485_CR72","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/jrr\/rrx015","volume":"58","author":"F Chen","year":"2017","unstructured":"Chen F, Shen M, Zeng D, Wang C, Wang S, Chen S, et al. Effect of radiation-induced endothelial cell injury on platelet regeneration by megakaryocytes. J Radiat Res. 2017;58(4):456\u201363. https:\/\/doi.org\/10.1093\/jrr\/rrx015.","journal-title":"J Radiat Res"},{"key":"8485_CR73","doi-asserted-by":"publisher","first-page":"12993","DOI":"10.1038\/srep12993","volume":"5","author":"C Wang","year":"2015","unstructured":"Wang C, Zhang B, Wang S, Zhang J, Liu Y, Wang J, et al. Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation. Sci Rep. 2015;5:12993. https:\/\/doi.org\/10.1038\/srep12993.","journal-title":"Sci Rep"},{"issue":"15","key":"8485_CR74","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","volume":"78","author":"AK Bhandage","year":"2021","unstructured":"Bhandage AK, Barragan A. GABAergic signaling by cells of the immune system: more the rule than the exception. Cell Mol Life Sci. 2021;78(15):5667\u201379. https:\/\/doi.org\/10.1007\/s00018-021-03881-z.","journal-title":"Cell Mol Life Sci"},{"issue":"7885","key":"8485_CR75","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature. 2021;599(7885):471\u201376. https:\/\/doi.org\/10.1038\/s41586-021-04082-1.","journal-title":"Nature"},{"key":"8485_CR76","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3389\/fimmu.2020.01869","volume":"11","author":"TW Hodo","year":"2020","unstructured":"Hodo TW, de Aquino MTP, Shimamoto A, Shanker A. Critical Neurotransmitters in the Neuroimmune Network. Front Immunol. 2020;11:1869. https:\/\/doi.org\/10.3389\/fimmu.2020.01869.","journal-title":"Front Immunol"},{"issue":"8","key":"8485_CR77","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","volume":"121","author":"Y Ganor","year":"2014","unstructured":"Ganor Y, Levite M. The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm (Vienna). 2014;121(8):983\u20131006. https:\/\/doi.org\/10.1007\/s00702-014-1167-5.","journal-title":"J Neural Transm (Vienna)"},{"key":"8485_CR78","doi-asserted-by":"publisher","unstructured":"Muller L, Di Benedetto S, Muller V. From Homeostasis to Neuroinflammation: Insights into Cellular and Molecular Interactions and Network Dynamics. Cells. 2025;14(1). https:\/\/doi.org\/10.3390\/cells14010054.","DOI":"10.3390\/cells14010054"},{"issue":"1","key":"8485_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41232-024-00352-3","volume":"44","author":"M Izumi","year":"2024","unstructured":"Izumi M, Nakanishi Y, Kang S, Kumanogoh A. Peripheral and central regulation of neuro-immune crosstalk. Inflamm Regen. 2024;44(1):41. https:\/\/doi.org\/10.1186\/s41232-024-00352-3.","journal-title":"Inflamm Regen"},{"issue":"11","key":"8485_CR80","doi-asserted-by":"publisher","first-page":"27796","DOI":"10.3390\/ijms161126068","volume":"16","author":"S Balentova","year":"2015","unstructured":"Balentova S, Adamkov M. Molecular, Cellular and Functional Effects of Radiation-Induced Brain Injury: A Review. Int J Mol Sci. 2015;16(11):27796\u2013815. https:\/\/doi.org\/10.3390\/ijms161126068.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8485_CR81","doi-asserted-by":"publisher","first-page":"22957","DOI":"10.1038\/s41598-024-72975-y","volume":"14","author":"MJ Aryankalayil","year":"2024","unstructured":"Aryankalayil MJ, Patel H, May JM, Shankavaram U, Bylicky MA, Martello S, et al. Whole-blood RNA biomarkers for predicting survival in non-human primates following thoracic radiation. Sci Rep. 2024;14(1):22957. https:\/\/doi.org\/10.1038\/s41598-024-72975-y.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08485-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:09:36Z","timestamp":1782904176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8485"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08485-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Experimental protocols were approved by the Uniformed Services University of Health Sciences Institutional Animal Care and Use Committee (IACUC) #PHA-23\u2013115 and the Animal Care and Use Review Office (ACURO). The authors confirm the current study is in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The opinions or assertions contained herein are the private views of the authors and are not necessarily those of the Uniformed Services University of the Health Sciences, or the Department of War.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"Dr. Kaytor is a current employee of Humanetics Corporation. The other authors report no conflicts of interest. Authors alone are responsible for the content and writing of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"835"}}